21 Oct 2022 --- Swedish probiotics company BioGaia is unveiling its financial results for Q3 2022. Sales amounted to SEK257.2 million (US$22.7 million), an increase of 48% resulting in SEK83.9 million (US$7.4 million) and organic growth of 21%.“Today we presented another strong quarter, which is the fifth consecutive quarter with double-digit growth. For the third quarter, we reported an increase of 50% in profit after taxes,” Alexander Kotsinas, CFO at BioGaia, tells NutritionInsight.
